Bleeding Disorder News and Research

RSS
Apitope's ATX-F8-117 granted orphan medicinal product designation for treatment of haemophilia A

Apitope's ATX-F8-117 granted orphan medicinal product designation for treatment of haemophilia A

Gene therapy transforms life for men with severe form of hemophilia B

Gene therapy transforms life for men with severe form of hemophilia B

Cases of Ebola virus in West Africa continue to rise

Cases of Ebola virus in West Africa continue to rise

Bayer, Dimension Therapeutics partner to develop new gene therapy for hemophilia A

Bayer, Dimension Therapeutics partner to develop new gene therapy for hemophilia A

FDA approves Bayer's Kogenate FS antihemophilic factor VIII to prevent bleeding episodes in adults with hemophilia A

FDA approves Bayer's Kogenate FS antihemophilic factor VIII to prevent bleeding episodes in adults with hemophilia A

Baxter reports topline results from BAX 111 Phase 3 trial for treatment of von Willebrand disease

Baxter reports topline results from BAX 111 Phase 3 trial for treatment of von Willebrand disease

Study outlines agenda to help direct future caffeine dependence research

Study outlines agenda to help direct future caffeine dependence research

CHOP scientist receives 2013 E. Donnall Thomas Prize for scientific, clinical research in hemophilia

CHOP scientist receives 2013 E. Donnall Thomas Prize for scientific, clinical research in hemophilia

CHOP scientist receives 2013 E. Donnall Thomas Prize for research in bleeding disorder hemophilia

CHOP scientist receives 2013 E. Donnall Thomas Prize for research in bleeding disorder hemophilia

Late-breaking abstracts on treatment of blood cancers and bleeding disorders presented at ASH meeting

Late-breaking abstracts on treatment of blood cancers and bleeding disorders presented at ASH meeting

New smartphone app for patients with hemophilia and related bleeding disorders

New smartphone app for patients with hemophilia and related bleeding disorders

UTHealth researchers find cause for rare type of bleeding disorder

UTHealth researchers find cause for rare type of bleeding disorder

FDA grants Orphan Drug Designation to Alnylam ALN-AT3 for treatment of hemophilia B

FDA grants Orphan Drug Designation to Alnylam ALN-AT3 for treatment of hemophilia B

CHOP-led research increases numbers of patients who could be treated with gene therapy

CHOP-led research increases numbers of patients who could be treated with gene therapy

Bayer starts enrollment in BAY94-9027 Phase II/III trial for hemophilia A in children

Bayer starts enrollment in BAY94-9027 Phase II/III trial for hemophilia A in children

Study sheds light on stem cell technique for treatment of common bleeding disorder

Study sheds light on stem cell technique for treatment of common bleeding disorder

Cardiovascular disease risk in women higher than you think

Cardiovascular disease risk in women higher than you think

Interim results from Inspiration’s OBI-1 and IB1001 hemophilia clinical study

Interim results from Inspiration’s OBI-1 and IB1001 hemophilia clinical study

Bayer completes recruitment of first cohort for BAY 86-6150 Phase II/III study in hemophilia

Bayer completes recruitment of first cohort for BAY 86-6150 Phase II/III study in hemophilia

Novo Nordisk launches HemaGo mobile app to help individuals with hemophilia

Novo Nordisk launches HemaGo mobile app to help individuals with hemophilia